Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats

被引:83
|
作者
Jose Zarzuelo, Maria [1 ]
Jimenez, Rosario [1 ,3 ]
Galindo, Pilar [1 ]
Sanchez, Manuel [1 ]
Nieto, Ana [4 ]
Romero, Miguel [1 ]
Maria Quintela, Ana [1 ]
Lopez-Sepulveda, Rocio [1 ]
Gomez-Guzman, Manuel [1 ]
Bailon, Elvira [1 ]
Rodriguez-Gomez, Isabel [2 ]
Zarzuelo, Antonio [1 ,5 ]
Galvez, Julio [1 ,5 ]
Tamargo, Juan [6 ]
Perez-Vizcaino, Francisco [6 ,7 ,8 ]
Duarte, Juan [1 ]
机构
[1] Univ Granada, Sch Pharm, Dept Pharmacol, E-18071 Granada, Spain
[2] Univ Granada, Sch Med, Dept Physiol, E-18071 Granada, Spain
[3] Ctr Biomed Res, Granada, Spain
[4] Anapath, Anat Pathol Lab, Granada, Spain
[5] Ciber Enfermedades Hepat & Digest, Madrid, Spain
[6] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain
[7] Ciber Enfermedades Resp, Madrid, Spain
[8] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
关键词
PPAR beta/delta; spontaneously hypertensive rat; endothelial dysfunction; NADPH oxidase; regulators of G protein-coupled signaling proteins; PROTEIN-KINASE-C; ANGIOTENSIN-II; OXIDATIVE STRESS; FATTY-ACID; PPAR-ALPHA; KAPPA-B; EXPRESSION; ENDOTHELIN-1; HEART; HYPERTROPHY;
D O I
10.1161/HYPERTENSIONAHA.111.174490
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta) has been shown to improve insulin resistance and plasma high-density lipoprotein levels, but nothing is known about its effects in genetic hypertension. We studied whether the PPAR beta agonist GW0742 might exert antihypertensive effects in spontaneously hypertensive rats (SHRs). The rats were divided into 4 groups, Wistar Kyoto rat-control, Wistar Kyoto rat-treated (GW0742, 5 mg . kg(-1) . day(-1) by oral gavage), SHR-control, and SHR-treated, and followed for 5 weeks. GW0742 induced a progressive reduction in systolic arterial blood pressure and heart rate in SHRs and reduced the mesenteric arterial remodeling, the increased aortic vasoconstriction to angiotensin II, and the endothelial dysfunction characteristic of SHRs. These effects were accompanied by a significant increase in endothelial NO synthase activity attributed to upregulated endothelial NO synthase and downregulated caveolin 1 protein expression. Moreover, GW0742 inhibited vascular superoxide production, downregulated p22(phox) and p47(phox) proteins, decreased both basal and angiotensin II-stimulated NADPH oxidase activity, inhibited extracellular-regulated kinase 1/2 activation, and reduced the expression of the proinflammatory and proatherogenic genes, interleukin 1 beta, interleukin 6, or intercellular adhesion molecule 1. None of these effects were observed in Wistar Kyoto rats. PPAR beta activation, both in vitro and in vivo, increased the expression of the regulators of G protein-coupled signaling proteins RGS4 and RGS5, which negatively modulated the vascular actions of angiotensin II. PPAR beta activation exerted antihypertensive effects, restored the vascular structure and function, and reduced the oxidative, proinflammatory, and proatherogenic status of SHRs. We propose PPAR beta as a new therapeutic target in hypertension. (Hypertension. 2011;58:733-743.)
引用
收藏
页码:733 / U437
页数:23
相关论文
共 50 条
  • [31] Peroxisome Proliferator-Activated Receptor-δ as Emerging Target in Liver Disease
    Schnabl, Bernd
    DRUG DEVELOPMENT RESEARCH, 2010, 71 (02) : 106 - 111
  • [32] Peroxisome proliferator-activated receptor-γ protects against vascular aging
    Modrick, Mary L.
    Kinzenbaw, Dale A.
    Chu, Yi
    Sigmund, Curt D.
    Faraci, Frank M.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2012, 302 (10) : R1184 - R1190
  • [33] Peroxisome proliferator-activated receptor-α accelerates α-chlorofatty acid catabolism
    Palladino, Elisa N. D.
    Wang, Wen-yi
    Albert, Carolyn J.
    Langhi, Cedric
    Baldan, Angel
    Ford, David A.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (02) : 317 - 324
  • [34] Absence of peroxisome proliferator-activated receptor-γ abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse
    Tordjman, Karen M.
    Semenkovich, Clay F.
    Coleman, Trey
    Yudovich, Rachel
    Bak, Stella
    Osher, Etty
    Vechoropoulos, Michal
    Stern, Naftali
    HYPERTENSION, 2007, 50 (05) : 945 - 951
  • [35] Activation of peroxisome proliferator-activated receptor-α and -γ in auricular tissue from heart failure patients
    Gómez-Garre, D
    Herraíz, M
    González-Rubio, ML
    Bernal, R
    Aragoncillo, P
    Carbonell, A
    Rufilanchas, JJ
    Fernández-Cruz, A
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (02) : 154 - 161
  • [36] Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes
    Lee, Joo-Young
    Hashizaki, Hikari
    Goto, Tsuyoshi
    Sakamoto, Tomoya
    Takahashi, Nobuyuki
    Kawada, Teruo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (04) : 818 - 822
  • [37] Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice
    Takei, Kenta
    Han, Song-iee
    Murayama, Yuki
    Satoh, Aoi
    Oikawa, Fusaka
    Ohno, Hiroshi
    Osaki, Yoshinori
    Matsuzaka, Takashi
    Sekiya, Motohiro
    Iwasaki, Hitoshi
    Yatoh, Shigeru
    Yahagi, Naoya
    Suzuki, Hiroaki
    Yamada, Nobuhiro
    Nakagawa, Yoshimi
    Shimano, Hitoshi
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (04) : 446 - 452
  • [38] Mode of Peroxisome Proliferator-Activated Receptor γ Activation by Luteolin
    Puhl, Ana C.
    Bernardes, Amanda
    Silveira, Rodrigo L.
    Yuan, Jing
    Campos, Jessica L. O.
    Saidemberg, Daniel M.
    Palma, Mario S.
    Cvoro, Aleksandra
    Ayers, Stephen D.
    Webb, Paul
    Reinach, Peter S.
    Skaf, Munir S.
    Polikarpov, Igor
    MOLECULAR PHARMACOLOGY, 2012, 81 (06) : 788 - 799
  • [39] Peroxisome Proliferator-Activated Receptor-γ Activation Prevents Sepsis-Related Cardiac Dysfunction and Mortality In Mice
    Drosatos, Konstantinos
    Khan, Raffay S.
    Trent, Chad M.
    Jiang, Hongfeng
    Son, Ni-Huiping
    Blaner, William S.
    Homma, Shunichi
    Schulze, P. Christian
    Goldberg, Ira J.
    CIRCULATION-HEART FAILURE, 2013, 6 (03) : 550 - +
  • [40] Activation of Peroxisome Proliferator-Activated Receptor-δ Enhances Regenerative Capacity of Human Endothelial Progenitor Cells by Stimulating Biosynthesis of Tetrahydrobiopterin
    He, Tongrong
    Smith, Leslie A.
    Lu, Tong
    Joyner, Michael J.
    Katusic, Zvonimir S.
    HYPERTENSION, 2011, 58 (02) : 287 - U337